Intellectual Property Protection and High Quality Development of Radix Glycyrrhizae for Treatment of COVID-19

Radix Glycyrrhizae is the dominant native medicinal material variety in the north and northwestern medicinal materials producing areas.It is a main Chinese medicine of effective TCM drugs and formulas for the treatment of new coronavirus disease(COVID-19).This paper introduces the medicinal value of Radix Glycyrrhizae,involving the labeling,cultural heritage,and creative intellectual property rights of the Chinese medicinal materials,analyzes the poverty-stricken areas that are ecologically suitable for Radix Glycyrrhizae cultivation,and the superior counties and production bases of the Chinese medicinal materials.Besides,mainly from the aspects of perfect intellectual property rights,the establishment of authentic medicinal material production bases,and the construction of quality control systems,etc.,it discusses the rural revitalization strategy and the development strategy of traditional Chinese medicine(TCM),agricultural intellectual property protection and high-quality development strategy of Radix Glycyrrhizae.

A systematic summary of natural compounds in Radix Glycyrrhizae

Objective： To accumulate data from studies on the compounds identified from Gancao （Radix Glycyrrhizae, GC）, andthen systematically summarize and classify these compounds according to their structural characteristics. Methods： Fivedatabases （CNKI, VIP, Wanfang data, CBM, and Pubmed） were used to search for studies on the chemical structure ofcompounds from GC. The retrieval time of the respective databases was from their inception to March 2016. Accordingto the inclusion and exclusion criteria, the papers were carefully screened, and the data were extracted. Results： A totalof 653 compounds from GC were collated from 252 articles, including flavonols （n = 201） belonging to 10 subgroups,terpenes and saponins （n = 167）, coumarins （n = 30） belonging to 3 subgroups, aliphatics （n = 206）, aromatics （n = 35）,and others （n = 14）. The flavones, represented by liquiritin and liquiritigenin, were the most reported compounds isolatedfrom GC, followed by terpenes and saponins such as glycyrrhizic acid and glycyrrhetinic acid. Conclusion： The morethan 600 natural compounds in GC may be responsible for GC’s anti-inflammatory, phlegm-expelling, cough- andpain-relieving activities.

Simultaneous Determination of Saponins in Radix Glycyrrhizae, Notoginseng and Ginseng by High Performance Liquid Chromatography

To establish a method for determining five saponins(notoginsenoside R1, ginsenoside Rg1, ginsenoside Re, ginsenoside Rb1 and ammonium glycyrrhizinate) in Glycyrrhizae, Notoginseng and Ginseng, the high performance liquid chromatography with diode array detector(HPLC-DAD) method was applied to an Inertsil ODS-SP column(4.6 mm×250 mm, 5 μm) with a mobile phase consisting of acetonitrile-0.05% phosphoric acid in a gradient elution manner. The flow rate was 1.0 mL/min. The column temperature was 30 ℃ and the detection wavelengths were 203 nm and 237 nm, respectively. The linear ranges were 0.700,0—7.000,0 μg for R1(r=1.000,0), 0.751,1— 7.511,4 μg for Rg1(r=1.000,0), 0.677,2—6.771,6 μg for Re(r=1.000,0), 0.733,9—7.339,1 μg for Rb1(r= 1.000,0), and 0.540,0—5.399,8 μg for ammonium glycyrrhizinate(r=0.999,9), respectively. In addition, their average recoveries were 100.28%, 105.83%, 104.09%, 99.36% and 98.54%, respectively. The relative standard deviations(RSDs) of precision, reproducibility and recovery were all less than 1.5%. The results indicate that the method is simple, accurate and reproducible so that it can be used for the simultaneous determination of the five saponins in Chinese patent medicines containing the three kinds of herbs.

Screening for cyclooxygenase 2 inhibitors from natural compounds of Radix Glycyrrhizae using computer simulation

Objective： To explore the molecular basis of the effects of Gancao （Radix Glycyrrhizae, GC） on inflammation throughthe inhibition of cyclooxygenase 2 （COX-2）. Methods： The Discovery Studio 4.5 System was used to predict thephysicochemical properties of GC molecular compounds. The Ligand Profiler was used to screen for natural GCcomponents that could combine with the COX-2 pharmacophores. The AutoDock Vina 1.1.2 software was used for themolecular docking of the natural GC components with the COX-2 protein. Results： The aromatics were the closest to thenon-steroidal anti-inflammatory drugs in terms of the three properties, namely molecular weight, molecular surface area,and molecular solubility, followed by the flavonoids; whereas the terpenoids/saponins differed most from thenon-steroidal anti-inflammatory drugs in terms of the three properties; and the aliphatics were inconsistent. One hundredand eighteen small molecules were obtained through the pharmacophore screening using GC. The molecular bindingenergy （MBE） results demonstrated that the MBE value of the flavonoids/aromatics, obtained from their binding with theCOX-2 protein, was lower than that obtained from their binding with the substrate, metabolism of arachidonic acid,whereas the MBE value of the aliphatics/terpenoids, obtained from their binding with the COX-2 protein, was higherthan that obtained from their binding with the substrate, arachidonic acid. Finally, further filtration, based on thephysicochemical properties and the molecular binding energies of the small molecules, was carried out. Forty-twonatural GC components, including 35 flavonoid and 7 aromatic constituents, with low binding energies and potentialinhibitory effects on COX-2, were screened. Conclusion： Using the three-step program, pharmacophore screening,molecular docking, and physicochemical properties analysis, we screened out 35 flavonoid molecules and 7 aromaticmolecules, which may be potential COX-2 inhibitors, from GC. Two of the 35 flavonoid molecules （licochalcone A andglabridin） have been confirmed in the laboratory to have inhibitory effects on COX-2. Our findings provide a materialbasis for the development of non-steroidal GC drugs.

Variations in the Composition of Fructus Evodiae after Processing with Radix Glycyrrhizae Extract

Objective： To evaluate the changes in the concentrations of five components in Fructus Evodiae used in Chinese medicine, including evodiamine and glycyrrhizic acid, during processing of Fructus Evodiae with Radix Glycyrrhizae extract by using high performance liquid chromatography （HPLC） and to provide a scientific basis for different clinical uses of processed and unprocessed Fructus Evodiae. Methods： The concentrations of the Fructus Evodiae components in processed or unprocessed Fructus Evodiae were evaluated by HPLC using a YMC J＇sphere ODS-H80 column （4.6 mm × 250 ram, 5 μm） with acetonitrile-water-tetrehydrofuran-acetic acid （41：59：1：0.2, v/v/v/v） as the mobile phase. The detection wavelength was 225 nm, the column temperature was 35 %, the flow rate was 1.0 mL/min, and the injection volume was 10 μL. The concentrations of the Radix Glycyrrhizae components were determined by HPLC with a KromasiI-C18 column （4.6 mm × 250 mm, 4 μm） and a gradient elution of acetonitrile （A） and 0.05% aqueous phosphoric acid （B） as the mobile phase. The detection wavelength was 237 nm, the column temperature was 35 ℃, the flow rate was 1.0 mlEmin, and the injection volume was 10μL. Results： The calibration curves of evodia lactone, evodiamine, rutaecarpine, liquiritin, and glycyrrhizin showed good linear relationships （r〉0.99）. The recoveries of evodia lactone, evodiamine, rutaecarpine, liquiritin, and glycyrrhizin were 96.59%, 104.18%, 101.91%, 97.75%, and 97.95%, respectively. The concentrations of the components in processed Fructus Evodiae were obviously different to those in unprocessed Fructus Evodiae. Conclusions： The developed method is rapid and accurate. The results provide a reference for processed Fructus Evodiae and the changes that could be expected in its effects compared to unprocessed Fructus Evodiae.

Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid

Glycyrrhizae Radix et Rhizoma,a traditional Chinese medicine also known as Gan Cao(GC),is frequently included in clinical prescriptions for the treatment of pneumonia.However,the pharmacological components of GC for pneumonia treatment are rarely explored.Gan An He Ji oral liquid(GAHJ)has a simple composition and contains GC liquid extracts and paregoric,and has been used clinically for many years.Therefore,GAHJ was selected as a compound preparation for the study of GC in the treatment of pneumonia.We conducted an in vivo study of patients with pneumonia undergoing GAHJ treatments for three days.Using the intelligent mass spectrometry data-processing technologies to analyze the metabolism of GC in vivo,we obtained 168 related components of GC in humans,consisting of 24 prototype components and 144 metabolites,with 135 compounds screened in plasma and 82 in urine.After analysis of the metabolic transformation relationship and relative exposure,six components(liquiritin,liquiritigenin,glycyrrhizin,glycyrrhetinic acid,daidzin,and formononetin)were selected as potential effective components.The experimental results based on two animal pneumonia models and the inflammatory cell model showed that the mixture of these six components was effective in the treatment of pneumonia and lung injury and could effectively downregulate the level of inducible nitric oxide synthase(iNOS).Interestingly,glycyrrhetinic acid exhibited the strongest inhibition on iNOS and the highest exposure in vivo.The following molecular dynamic simulations indicated a strong bond between glycyrrhetinic acid and iNOS.Thus,the current study provides a pharmaceutical basis for GC and reveals the possible corresponding mechanisms in pneumonia treatment.

甘草抗炎活性物质基础及其作用机制研究进展

炎症是机体对于刺激所产生的一种防御反应,随着炎症的发展可能导致组织的变异和增生,进一步加剧疾病的进程。甘草作为“众药之王”“国之药老”,早在《神农本草经》中就记载其清热作用较强,能“主五脏六腑寒热邪气”。现代研究表明,甘草提取物对肾小球肾炎、结肠炎症状改善明显,甘草及其制剂在治疗肝炎、胃炎、支气管炎、心肌炎、强直性脊柱炎等炎症性疾病方面亦具有一定的独特优势和发展潜力。该文旨在通过对近期国内外甘草抗炎活性物质基础及其作用机制方面的相关文献进行收集和整理,探索甘草发挥抗炎作用的主要活性成分及靶点通路,以期为甘草抗炎作用的进一步研究及抗炎药物的研发提供思路和参考。

解郁清心颗粒的定性鉴别和含量限度的制定

摸索解郁清心颗粒的定性鉴别和指标成分含量限度制定方法。采用TLC法对制剂中炒白芍、甘草进行定性鉴别;采用HPLC法对制剂中芍药苷的含量进行测定并制定含量限度。TLC用于方中药味鉴别分离度良好,供试品与对照品对应处有相同颜色的斑点,阴性无干扰。采用HPLC法测定的指标成分芍药苷的含量限度建议为≥0.8 mg/g。本实验得到的定性鉴别方法和指标成分的含量限度制定方法均具较强的专属性、准确性和可靠性,可为该制剂质控标准提供参考依据。

炒白芍-炙甘草配伍前后化学成分与抗炎作用相关性研究

目的明确炒白芍-炙甘草配伍对化学成分的影响及其与抗炎作用的相关性。方法采用HPLCDAD建立同时测定炒白芍-炙甘草中芍药苷、芍药内酯苷、苯甲酰芍药苷、氧化芍药苷、甘草酸、甘草苷多成分含量的分析方法;建立佐剂性关节炎大鼠模型,给药组分别灌胃炒白芍、炙甘草、炒白芍-炙甘草药液2周,ELISA检测大鼠血清炎症因子白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、前列腺素E_(2)(PGE_(2))含量;采用析因设计、双变量相关分析、多元线性回归方法研究配伍对化学成分的影响及其与抗炎药效的相关性。结果建立HPLC-DAD分析方法,炒白芍-炙甘草配伍后氧化芍药苷、芍药内酯苷、苯甲酰芍药苷含量增加(P<0.05);与模型组比较,各给药组大鼠血清IL-1β、TNF-α、PGE_(2)含量降低(P<0.01),且配伍组血清IL-1β、TNF-α、PGE_(2)含量低于炒白芍组、炙甘草组(P<0.05,P<0.01);析因设计结果显示炒白芍-炙甘草配伍存在交互效应,双变量相关分析结果显示氧化芍药苷、芍药内酯苷、芍药苷、甘草苷、苯甲酰芍药苷、甘草酸含量分别与IL-1β、TNF-α、PGE_(2)含量呈负相关,多元线性回归结果显示甘草苷、甘草酸与IL-1β、TNF-α、PGE_(2)含量呈负相关。结论本研究建立的炒白芍-炙甘草多成分含量分析方法简便快捷、专属性强、准确可靠,可用于其质量评价与控制。炒白芍-炙甘草配伍可抑制炎症因子IL-1β、TNF-α、PGE_(2)表达,且化学成分含量与抗炎作用具有相关性。

甘草颗粒特征图谱及其质量相关性研究

建立甘草颗粒中甘草苷、甘草酸铵含量检测方法并进行指纹图谱研究。采用高效液相色谱法,色谱柱为Eclipse Plus C_(18)柱(4.6 mm×250.0 mm,5μm),检测波长237 nm,以乙腈(A)-0.05%磷酸(B)为流动相,梯度洗脱,流速为1.0 mL/min,柱温为30℃,进样量10μL。结果显示,10批样品有12个共有峰,相似度大于0.901。经对照品比对,指认甘草苷和甘草酸铵两个指标性成分并对其进行定量分析,线性关系良好(R^(2)>0.9998),平均加样回收率为99.67%~102.42%。该方法操作简单、快捷,结果准确,可以甘草颗粒中甘草苷、甘草酸铵含量的测定对甘草颗粒进行质量评价。

芍药甘草汤美白保湿乳液的研制

以传统方剂芍药甘草汤为基础,制备一款乳液并对其美白、保湿功效进行评价;制备赤芍、甘草提取液,采用DPPH自由基清除试验,筛选出两种提取液各自的最佳抗氧化浓度及复配比例;采用单因素实验法优化乳液基质配方,得到复配液最佳添加量;采用络氨酸酶活性抑制实验对乳液的美白功效进行评价;采用CM825皮肤水分测试仪对乳液的保湿功效进行评价;对比护肤乳液(国家标准QB/T 29665—2013)检验指标要求,对乳液成品的感官理化性质进行评价;通过斑贴试验检验乳液的刺激性。结果表明,将甘草和赤芍提取液,以2∶3体积比例复配,制得的甘草赤芍乳液,美白、保湿能力良好,质地均匀,使用感舒适,感官理化性质良好,耐热、耐寒、安全性等指标符合化妆品规范标准。

基于整合药理学探讨“茯苓-甘草”协同配伍对肺腺癌的作用机制及验证研究

目的:基于网络药理学和生物信息学探讨“茯苓-甘草”协同配伍对肺腺癌的作用机制及靶点,并通过实验验证“茯苓-甘草”主要成分槲皮素对肺腺癌的抑制作用。方法:对肺腺癌相关基因进行差异分析,从TCMSP数据库下载“茯苓-甘草”有效成分及靶标,获取药物-疾病共同靶标,进行网络构建、富集分析、生存分析等。通过对“茯苓-甘草”主要成分与肺腺癌关键靶点进行分子对接,选出构效关系良好的有效成分进行后续实验验证。通过细胞增殖、划痕及侵袭实验检测药物对肺腺癌细胞的干预作用,实时荧光定量法检测药物对关键靶点的作用。结果:肺腺癌8 109个差异表达基因和102个药物靶基因取交集共获得32个共同基因,富集分析显示靶基因主要参与p53信号通路、细胞衰老等癌症相关通路,分子对接结果显示槲皮素具有良好的构效关系,因此选择槲皮素进行后续实验验证。有效成分槲皮素可以抑制肺腺癌A549及H1299细胞的增殖、迁移及侵袭能力,并且可以显著下调关键靶点含杆状病毒IAP重复序列蛋白5(BIRC5)、细胞周期蛋白B1(CCNB1)、检查点蛋白激酶1(CHEK1)的表达。结论“:茯苓-甘草”有效成分槲皮素可以有效抑制肺腺癌恶性表型,其机制可能与靶向调节关键基因BIRC5、CCNB1、CHEK1的表达有关。

甘草预防气管插管致呼吸道损伤的有效成分筛选

背景术后咽喉痛(POST)是全身麻醉后常见的轻微但令人不悦的术后并发症之一。研究发现甘草能有效降低POST的发生率,但其有效成分尚不清楚。目的筛选甘草预防气管插管致呼吸道损伤的有效成分。方法2021年4月—2022年7月将60只SPF级Wistar大鼠依据随机数字表法分为对照组、气管插管组、利多卡因组、总多糖组、总皂苷组、总黄酮组,每组10只。除对照组外,其余组制备气管插管模型,插管前各治疗组按1 mL/100 g(按体质量计)分别经口喷入1%利多卡因、总多糖、总皂苷、总黄酮,浸润悬雍垂及软腭周围组织,对照组和气管插管组经口喷入等体积0.9%氯化钠溶液。机械通气2 h后拔除气管导管,深麻醉下收集大鼠咽部黏膜组织和血液标本,通过苏木精-伊红染色法(HE染色)和免疫组化(IHC)观察大鼠咽部黏膜病理变化和Toll样受体2(TLR2)、Toll样受体4(TLR4)表达水平;酶联免疫吸附测定法(ELISA)检测大鼠血清炎性因子[肿瘤坏死因子α(TNF-α)、白介素(IL)-2、IL-4、IL-10]、氧化应激[超氧化物歧化酶(SOD)、丙二醛(MDA)、总抗氧化能力(T-AOC)]及应激激素[皮质醇(Cor)、肾上腺素(E)和去甲肾上腺素(NE)]表达水平。结果HE染色显示气管插管组可见黏膜脱落,黏膜下结构严重破坏并伴有大量炎性细胞浸润,总皂苷组大鼠咽部黏膜组织破坏较轻,炎性细胞明显减少。ELISA结果显示:与对照组相比,气管插管组大鼠血清中的TNF-α、IL-2水平升高,IL-4、IL-10水平降低(P<0.05);与气管插管组相比,总皂苷组大鼠血清中TNF-α和IL-2水平降低,IL-4和IL-10水平升高(P<0.05)。与对照组相比,气管插管组大鼠血清中MDA水平升高,SOD和T-AOC水平下降(P<0.05);与气管插管组相比,总皂苷组和总黄酮组大鼠血清中MDA水平降低,SOD和T-AOC水平升高(P<0.05)。与对照组相比,气管插管组大鼠血清Cor、E和NE水平升高(P<0.05);与气管插管组相比,总皂苷组大鼠血清Cor、E和NE水平降低(P<0.05)。IHC结果显示:气管插管组大鼠咽部黏膜组织TLR2和TLR4表达的平均光密度(AOD)高于对照组(P<0.05)。与气管插管组相比,总皂苷组大鼠咽部黏膜组织TLR4表达的AOD降低(P<0.05)。结论甘草预防全身麻醉气管插管致呼吸道损伤的主要有效成分为总皂苷。

甘草中三萜皂苷类成分抗肿瘤及联合抗肿瘤机制研究进展

甘草中三萜皂苷包括甘草酸、甘草次酸、乌拉尔甘草皂苷等,是甘草的主要活性成分之一。近年来,甘草三萜皂苷在抗肝癌、乳腺癌、肺癌等肿瘤及联合抗肿瘤方面的研究取得了一定进展。其可通过诱导肿瘤细胞凋亡、自噬、调控信息通路等机制抑制肿瘤细胞的增殖,在肿瘤的治疗上具有药用价值。

不同炮制方法对甘草化学成分及药理作用的影响研究

目的研究不同炮制方法对甘草化学成分和药理作用的影响。方法分析对比有关炮制对甘草化学成分及药理作用影响的相关文章,并以其化学成分及药理作用的变化为重点,依次进行梳理。结果甘草炮制方法较多且在临床上使用广泛,而不同炮制方法则会对其化学成分产生一定的影响,进而影响其药理作用。结论中药炮制与临床用药十分密切,只有选用恰当的炮制品入药,才能使其在临床上发挥更好的药物疗效,理清不同甘草炮制方法对化学成分和药理作用的影响情况,以期对甘草的深入开发利用和指导临床用药提供一些参考。

甘草对雷公藤治疗类风湿关节炎减毒增效的研究进展

雷公藤是中医治疗风湿性疾病常用的中草药,对以类风湿关节炎(rheumatoid arthritis,RA)为主的风湿性疾病起到良好的治疗作用,但由于其存在的不良反应使得该药的使用受到限制。甘草是中医传统的解毒药物,以甘草对雷公藤治疗RA为例,通过对近些年的文献进行综述,发现甘草可以通过影响机体的应答以及影响药物在体内的代谢过程对雷公藤治疗RA起到减毒增效的作用。既往尚未有综述对这方面的内容进行讨论,希望通过综述,能为安全使用雷公藤及其相关制剂提供技术参考,为RA的发病机制研究提供理论依据,以及对复方的研究和新药的研发提供思路。

甘草中20种无机元素的测定及对有害元素的健康风险评估

目的测定甘草中无机元素含量,并对重金属及有害元素进行污染分析及健康风险评估。方法采用电感耦合等离子体质谱法及原子荧光光谱法测定甘草中的无机元素含量及数据分析。通过计算样品中Pb、Cd、As、Hg和Cu5种重金属及有害元素的单向污染指数和综合污染指数对其进行安全性评价,通过计算每日最大可耐受摄入量(maximum tolerable daily intake,EDI)、靶标危害系数(target hazard quotients,THQ)和致癌风险(carcinogenic risk,CR),对甘草中5种重金属元素和有害元素进行健康风险评估,计算出甘草中各重金属的推荐重金属限量值(maximumresiduelimit,MRL)。结果得到的各无机元素在各自范围内线性关系良好(0.9969≤R2≤0.9996),样品稳定性、重复性、加标回收率及仪器精密度良好;Cr、Mn、Ni、Cu、Rb、Sr和Ba元素含量较高,并且各样品间各元素含量具有一致性和差异性;主成分分析中22个样品得到5个主成分,累计方差贡献率达84.308%,确定Ga、V、Cs、Se、Co、As、U、Ni、Cd和Hg是甘草的特征无机元素;相关性分析结果与主成分分析结果基本一致;健康风险评估结果显示甘草样品均对暴露人群无明显健康危害,其致癌风险也可忽略不计。结论本研究所建立的方法可有效进行甘草无机元素的测定及来源判别,并为甘草健康风险评估提供了科学依据。

排石合剂质量标准的提升及安全性评价

目的 提升排石合剂的质量标准,并对其安全性进行评价。方法 本制剂中的牡丹皮、甘草、桃仁采用薄层色谱法(TLC)进行鉴别。采用高效液相色谱法(HPLC)测定方中的丹皮酚的含量,色谱柱为Waters Xbridge R C_(18)(250 mm×4.6 mm,5μm),流动相为甲醇-水(45:55,V/V),流速为1.0 ml/min,检测波长为274 nm,柱温为35℃,进样量为10μl。样品以微波消解处理后,采用电感耦合等离子体质谱法测定其中所含的铅、砷、镉、汞、铜含量。结果 TLC法专属性强,阴性对照色谱图显示无干扰,牡丹皮、甘草、桃仁的特征斑点分明。丹皮酚浓度在10.5~104.9μg/ml范围内与峰面积线性关系良好(r=0.9999);加样回收率为100.1%,RSD为0.51%(n=6);精密度、稳定性、重复性试验结果的RSD均小于1.00%;12批样品中,丹皮酚平均含量为1203.04μg/ml。铅、砷、镉、汞、铜含量均在规定限度内。结论 本试验建立的质量标准可用于排石合剂的质量控制,操作方法简单且结果准确、可靠。排石合剂中铅、砷、镉、汞、铜含量符合国家标准,可安全用于患者。

林昌松辨治白塞病经验

白塞病可归属于中医“狐惑病”范畴。林昌松教授认为,白塞病乃本虚标实之证,肝郁脾虚为白塞病的根本病机,外感邪气为其发病诱因,湿热内蕴为其证候表现。林昌松教授采用《金匮要略》所载的甘草泻心汤,重用甘草,自拟“白塞方”“口炎方”治疗白塞病,取得了良好的临床疗效。林昌松教授基于中医经典的原文记载及临床用药经验,提出甘草之用量宜大,常用30~40 g。针对脾胃虚弱证明显的白塞病患者,治以“白塞方”(由炙甘草、党参、鹿衔草、法半夏、干姜、黄芩、黄连等组成)加减,宜用炙甘草;针对湿热炽盛的白塞病患者,拟“口炎方”(组成药物为生甘草、黄芩、黄连、法半夏、干姜、大枣、太子参、薄树芝、淡竹叶、车前子等)治疗,宜用生甘草。同时强调患者平素“食饮有节,起居有常,不妄作劳”对防止白塞病复发的重要性。

樟帮法甘草制吴茱萸指纹图谱的建立及生物碱类成分的含量测定

目的 建立樟帮法甘草制吴茱萸(以下简称“泡吴茱萸”)的HPLC指纹图谱,并同时测定吴茱萸碱、吴茱萸次碱、吴茱萸新碱的含量,为泡吴茱萸的质量控制及标准提高提供依据。方法 基于多波长切换法建立泡吴茱萸的指纹图谱,并进行相似度评价;以吴茱萸次碱为内参物,采用斜率校正法计算吴茱萸碱、吴茱萸新碱的相对校正因子,并比较一测多评(QAMS)法与外标法测定结果的差异。结果 建立了泡吴茱萸的指纹图谱,共有20个共有峰,与对照指纹图谱的相似度为0.970~0.998,共指认了7个共有峰;10批样品中QAMS法测定的吴茱萸碱、吴茱萸新碱的含量为1.754~7.542 mg/g和1.281~2.455mg/g,QAMS法与外标法两种检测方法所得结果相似。结论 所建立的HPLC法简单、可靠,分离度、重复性良好,可用于泡吴茱萸的质量评价。